Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia

Simple item page
dc.catalogadorasg
dc.contributor.authorJeanluc Bertrand
dc.contributor.authorHana Dostálová
dc.contributor.authorVladimir Krystof
dc.contributor.authorRadek Jorda
dc.contributor.authorThalía Delgado
dc.contributor.authorAlejandro Castro-Alvarez
dc.contributor.authorjaime mella
dc.contributor.authorDavid Cabezas
dc.contributor.authorMario Faúndez
dc.contributor.authorChristian Espinosa-Bustos
dc.contributor.authorSalas Sanchez, Cristian Osvaldo
dc.date.accessioned2024-03-04T15:34:36Z
dc.date.available2024-03-04T15:34:36Z
dc.date.issued2022
dc.fechaingreso.objetodigital2024-05-31
dc.fuente.origenORCID
dc.identifier.doi10.3390/pharmaceutics14061294
dc.identifier.urihttps://doi.org/10.3390/pharmaceutics14061294
dc.identifier.urihttps://www.mdpi.com/1999-4923/14/6/1294
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/83334
dc.information.autorucEscuela de Química; Salas Sanchez, Cristian Osvaldo; 0000-0001-7620-2459; 101425
dc.language.isoen
dc.nota.accesoContenido completo
dc.rightsacceso abierto
dc.titleDesign, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia
dc.typeartículo
sipa.codpersvinculados101425
sipa.trazabilidadORCID;2024-01-22
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
pharmaceutics-14-01294-v2.pdf
Size:
10.93 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas